Sec. 10.52.01.02. Definitions

A. In this chapter, the following terms have the meaning indicated.

B. Terms Defined.

(1) “Applicant” means a local health department or community-based organization seeking to establish an opioid-associated disease prevention and outreach program.

(2) Body Fluid.

(a) “Body fluid” means any fluid containing visible blood, semen, or vaginal secretions.

(b) “Body fluid” does not include cerebrospinal fluid, synovial fluid, breast milk, amniotic fluid, saliva, stool, nasal secretions, sputum, tears, urine, or vomitus.

(3) “Community-based organization (CBO)” means a public or private organization that:

(a) Is representative of a community or significant segments of a community; and

(b) Provides educational, health, or social services to individuals in the community.

(4) “Department” means the Maryland Department of Health.

(5) “Harm reduction education” means education on practical strategies:

(a) To reduce negative consequences associated with drug use; and

(b) That reflect specific individual and community needs.

(6) “HIV” means the human immunodeficiency virus that causes acquired immune deficiency syndrome (AIDS).

(7) “Infection control” means infection prevention and control measures that ensure the protection of individuals who are vulnerable to acquiring an infection both in the general community and while receiving health care services in a range of settings.

(8) “Injection supplies” means materials used to inject drugs including, but not limited to:

(a) Cookers;

(b) Water; and

(c) Cotton.

(9) “Naloxone” means an opioid antagonist indicated for the emergency treatment of known or suspected opioid overdose, as manifested by respiratory or central nervous system depression.

(10) “OADPO program” means an opioid-associated disease prevention and outreach program established by a local health department or community-based organization that provides services including:

(a) Dissemination of hypodermic needles or syringes and other preventive means for curtailing the spread of HIV and viral hepatitis;

(b) Overdose prevention education; and

(c) Harm reduction education.

(11) “Participant” means an individual who has registered with an OADPO program.

(12) “Sexually transmitted infection (STI)” means an infection passed from one person to another person through sexual contact.

(13) “Viral hepatitis” means inflammation of the liver caused by the hepatitis A, B, C, D, and E viruses.

(14) “Wound care” means treatment of the symptoms of infections that may result from using drugs.